Skip to main content
Top
Published in:

Open Access 01-12-2024 | Cardiac Diagnostics | Review

Epicardial fat density obtained with computed tomography imaging - more important than volume?

Authors: Łukasz Nogajski, Maciej Mazuruk, Marta Kacperska, Mikołaj Kurpias, Maciej Mączewski, Maksymilian Nowakowski, Michał Mączewski, Ilona Michałowska, Przemysław Leszek, Aleksandra Paterek

Published in: Cardiovascular Diabetology | Issue 1/2024

Login to get access

Abstract

Epicardial adipose tissue (EAT) is a unique fat depot located between the myocardium and the visceral layer of pericardium. It can be further subdivided into pericoronary (PCAT), periatrial (PAAT) and periventricular adipose tissue (PVentAT), each of them exhibiting specific characteristics and association with the underlying tissue. Since no physical barrier separates EAT from the myocardium, this fat tissue can easily interact with the underlying cardiac structure. EAT can be visualized using various imaging modalities. Computed tomography provides not only information on EAT volume, but also on its density. Indeed, EAT density reflected by the recently developed fat attenuation index (FAI) is emerging as a useful index of PCAT inflammation, PAAT inflammation and fibrosis, while the relevance of density of PVentAT is much less known. The emerging data indicates that FAI can be an important diagnostic and prognostic tool in both coronary artery disease and atrial fibrillation. Future studies will demonstrate if it also could be used as a marker of efficacy of therapies and whether FAI PVentAT could indicate ventricular pathologies, such as heart failure. The aim of the review is to present computed tomography derived FAI as an important tool both to study and better understand the epicardial fat and as a potential predictive marker in cardiovascular disorders.
Literature
2.
go back to reference Paterek A, Załęska-Kocięcka M, Wojdyńska Z et al. Epicardial fat in heart failure - friend, foe or bystander. Obes Rev. 2024;In Press. Paterek A, Załęska-Kocięcka M, Wojdyńska Z et al. Epicardial fat in heart failure - friend, foe or bystander. Obes Rev. 2024;In Press.
4.
go back to reference Wu C-K, Lee J-K, Hsu J-C, et al. Myocardial adipose deposition and the development of heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22:445–54.PubMedCrossRef Wu C-K, Lee J-K, Hsu J-C, et al. Myocardial adipose deposition and the development of heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22:445–54.PubMedCrossRef
5.
go back to reference Rabkin SW. Epicardial fat: properties, function and relationship to obesity. Obes Rev. 2007;8:253–61.PubMedCrossRef Rabkin SW. Epicardial fat: properties, function and relationship to obesity. Obes Rev. 2007;8:253–61.PubMedCrossRef
6.
go back to reference Westaby JD, Zullo E, Bicalho LM, Anderson RH, Sheppard MN. Effect of sex, age and body measurements on heart weight, atrial, ventricular, valvular and sub-epicardial fat measurements of the normal heart. Cardiovasc Pathol. 2023;63:107508.PubMedCrossRef Westaby JD, Zullo E, Bicalho LM, Anderson RH, Sheppard MN. Effect of sex, age and body measurements on heart weight, atrial, ventricular, valvular and sub-epicardial fat measurements of the normal heart. Cardiovasc Pathol. 2023;63:107508.PubMedCrossRef
7.
go back to reference Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88:5163–8.PubMedCrossRef Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88:5163–8.PubMedCrossRef
8.
go back to reference Eiras S, Teijeira-Fernández E, Salgado-Somoza A, et al. Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression. Cytokine. 2010;51:207–12.PubMedCrossRef Eiras S, Teijeira-Fernández E, Salgado-Somoza A, et al. Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression. Cytokine. 2010;51:207–12.PubMedCrossRef
9.
go back to reference Aitken-Buck HM, Moharram M, Babakr AA, et al. Relationship between epicardial adipose tissue thickness and epicardial adipocyte size with increasing body mass index. Adipocyte. 2019;8:412–20.PubMedPubMedCentralCrossRef Aitken-Buck HM, Moharram M, Babakr AA, et al. Relationship between epicardial adipose tissue thickness and epicardial adipocyte size with increasing body mass index. Adipocyte. 2019;8:412–20.PubMedPubMedCentralCrossRef
10.
go back to reference Aitken-Buck HM, Babakr AA, Coffey S, Jones PP, Tse RD, Lamberts RR. Epicardial adipocyte size does not correlate with body mass index. Cardiovasc Pathol. 2019;43:107144.PubMedCrossRef Aitken-Buck HM, Babakr AA, Coffey S, Jones PP, Tse RD, Lamberts RR. Epicardial adipocyte size does not correlate with body mass index. Cardiovasc Pathol. 2019;43:107144.PubMedCrossRef
11.
go back to reference Waddell HMM, Moore MK, Herbert-Olsen MA, et al. Identifying sex differences in predictors of epicardial fat cell morphology. Adipocyte. 2022;11:325–34.PubMedPubMedCentralCrossRef Waddell HMM, Moore MK, Herbert-Olsen MA, et al. Identifying sex differences in predictors of epicardial fat cell morphology. Adipocyte. 2022;11:325–34.PubMedPubMedCentralCrossRef
12.
go back to reference Arora RC, Waldmann M, Hopkins DA, Armour JA. Porcine intrinsic cardiac ganglia. Anat Rec A Discov Mol Cell Evol Biol. 2003;271A:249–58.CrossRef Arora RC, Waldmann M, Hopkins DA, Armour JA. Porcine intrinsic cardiac ganglia. Anat Rec A Discov Mol Cell Evol Biol. 2003;271A:249–58.CrossRef
13.
go back to reference Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247:289–98.PubMedCrossRef Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247:289–98.PubMedCrossRef
14.
go back to reference Marchington JM, Pond CM. Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes. 1990;14:1013–22.PubMed Marchington JM, Pond CM. Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes. 1990;14:1013–22.PubMed
15.
go back to reference Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B Comp Biochem. 1989;94:225–32.CrossRef Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B Comp Biochem. 1989;94:225–32.CrossRef
16.
go back to reference Greulich S, Maxhera B, Vandenplas G, et al. Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction. Circulation. 2012;126:2324–34.PubMedCrossRef Greulich S, Maxhera B, Vandenplas G, et al. Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction. Circulation. 2012;126:2324–34.PubMedCrossRef
17.
go back to reference Ballasy NN, Jadli AS, Edalat P, et al. Potential role of epicardial adipose tissue in coronary artery endothelial cell dysfunction in type 2 diabetes. FASEB J. 2021;35:e21878.PubMedCrossRef Ballasy NN, Jadli AS, Edalat P, et al. Potential role of epicardial adipose tissue in coronary artery endothelial cell dysfunction in type 2 diabetes. FASEB J. 2021;35:e21878.PubMedCrossRef
18.
go back to reference Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460–6.PubMedCrossRef Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460–6.PubMedCrossRef
19.
go back to reference Greulich S, de Wiza DH, Preilowski S, et al. Secretory products of guinea pig epicardial fat induce insulin resistance and impair primary adult rat cardiomyocyte function. J Cell Mol Med. 2011;15:2399–410.PubMedPubMedCentralCrossRef Greulich S, de Wiza DH, Preilowski S, et al. Secretory products of guinea pig epicardial fat induce insulin resistance and impair primary adult rat cardiomyocyte function. J Cell Mol Med. 2011;15:2399–410.PubMedPubMedCentralCrossRef
20.
go back to reference Venteclef N, Guglielmi V, Balse E, et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 2015;36:795–805a.PubMedCrossRef Venteclef N, Guglielmi V, Balse E, et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 2015;36:795–805a.PubMedCrossRef
21.
go back to reference Antoniades C, Tousoulis D, Vavlukis M, et al. Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers: A clinical consensus statement from the European Society of Cardiology Working Group on coronary pathophysiology and micro-circulation. Eur Heart J. 2023;44:3827–44.PubMedPubMedCentralCrossRef Antoniades C, Tousoulis D, Vavlukis M, et al. Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers: A clinical consensus statement from the European Society of Cardiology Working Group on coronary pathophysiology and micro-circulation. Eur Heart J. 2023;44:3827–44.PubMedPubMedCentralCrossRef
22.
go back to reference Antonopoulos AS, Sanna F, Sabharwal N et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017;9. Antonopoulos AS, Sanna F, Sabharwal N et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017;9.
23.
go back to reference Margaritis M, Antonopoulos AS, Digby J, et al. Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation. 2013;127:2209–21.PubMedCrossRef Margaritis M, Antonopoulos AS, Digby J, et al. Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation. 2013;127:2209–21.PubMedCrossRef
24.
go back to reference Antonopoulos AS, Margaritis M, Coutinho P, et al. Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue. Diabetes. 2014;64:2207–19.PubMedCrossRef Antonopoulos AS, Margaritis M, Coutinho P, et al. Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue. Diabetes. 2014;64:2207–19.PubMedCrossRef
25.
26.
go back to reference Vigmond EJ, Efimov IR, Rentschler SL, Coronel R, Boukens BJ. Fractionated electrograms with ST-segment elevation recorded from the human right ventricular outflow tract. HeartRhythm Case Rep. 2017;3:546–50.PubMedPubMedCentralCrossRef Vigmond EJ, Efimov IR, Rentschler SL, Coronel R, Boukens BJ. Fractionated electrograms with ST-segment elevation recorded from the human right ventricular outflow tract. HeartRhythm Case Rep. 2017;3:546–50.PubMedPubMedCentralCrossRef
27.
go back to reference Pouliopoulos J, Chik WW, Kanthan A, et al. Intramyocardial adiposity after myocardial infarction: new implications of a substrate for ventricular tachycardia. Circulation. 2013;128:2296–308.PubMedCrossRef Pouliopoulos J, Chik WW, Kanthan A, et al. Intramyocardial adiposity after myocardial infarction: new implications of a substrate for ventricular tachycardia. Circulation. 2013;128:2296–308.PubMedCrossRef
28.
go back to reference Załęska-Kocięcka M, Wojdyńska Z, Kalisz M, et al. Epicardial fat and ventricular arrhythmias. Heart Rhythm. 2024;21:206–12.PubMedCrossRef Załęska-Kocięcka M, Wojdyńska Z, Kalisz M, et al. Epicardial fat and ventricular arrhythmias. Heart Rhythm. 2024;21:206–12.PubMedCrossRef
29.
go back to reference Echols JT, Wang S, Patel AR, Hogwood AC, Abbate A, Epstein FH. Fatty acid composition MRI of epicardial adipose tissue: Methods and detection of proinflammatory biomarkers in ST-segment elevation myocardial infarction patients. Magn Reson Med. 2024;n/a:1–17. Echols JT, Wang S, Patel AR, Hogwood AC, Abbate A, Epstein FH. Fatty acid composition MRI of epicardial adipose tissue: Methods and detection of proinflammatory biomarkers in ST-segment elevation myocardial infarction patients. Magn Reson Med. 2024;n/a:1–17.
30.
go back to reference Antonopoulos AS, Antoniades C. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol. 2017;595:3907–17.PubMedPubMedCentralCrossRef Antonopoulos AS, Antoniades C. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol. 2017;595:3907–17.PubMedPubMedCentralCrossRef
31.
go back to reference Oikonomou EK, Marwan M, Desai MY, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet (London, England). 2018;392:929–39.PubMedCrossRef Oikonomou EK, Marwan M, Desai MY, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet (London, England). 2018;392:929–39.PubMedCrossRef
32.
go back to reference Oikonomou EK, Williams MC, Kotanidis CP, et al. A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J. 2019;40:3529–43.PubMedPubMedCentralCrossRef Oikonomou EK, Williams MC, Kotanidis CP, et al. A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J. 2019;40:3529–43.PubMedPubMedCentralCrossRef
33.
go back to reference Lin A, Nerlekar N, Yuvaraj J, et al. Pericoronary adipose tissue computed tomography attenuation distinguishes different stages of coronary artery disease: a cross-sectional study. Eur Heart J Cardiovasc Imaging. 2020;22:298–306.PubMedCentralCrossRef Lin A, Nerlekar N, Yuvaraj J, et al. Pericoronary adipose tissue computed tomography attenuation distinguishes different stages of coronary artery disease: a cross-sectional study. Eur Heart J Cardiovasc Imaging. 2020;22:298–306.PubMedCentralCrossRef
34.
go back to reference Farag SI, Mostafa SA, El-Rabbat KE, El-Kaffas SM, Awara DM. The relation between pericoronary fat thickness and density quantified by coronary computed tomography angiography with coronary artery disease severity. Indian Heart J. 2023;75:53–8.PubMedPubMedCentralCrossRef Farag SI, Mostafa SA, El-Rabbat KE, El-Kaffas SM, Awara DM. The relation between pericoronary fat thickness and density quantified by coronary computed tomography angiography with coronary artery disease severity. Indian Heart J. 2023;75:53–8.PubMedPubMedCentralCrossRef
35.
go back to reference Wen D, Li J, Ren J, Zhao H, Li J, Zheng M. Pericoronary adipose tissue CT attenuation and volume: diagnostic performance for hemodynamically significant stenosis in patients with suspected coronary artery disease. Eur J Radiol. 2021;140:109740.PubMedCrossRef Wen D, Li J, Ren J, Zhao H, Li J, Zheng M. Pericoronary adipose tissue CT attenuation and volume: diagnostic performance for hemodynamically significant stenosis in patients with suspected coronary artery disease. Eur J Radiol. 2021;140:109740.PubMedCrossRef
36.
go back to reference Hoshino M, Yang S, Sugiyama T, et al. Peri-coronary inflammation is associated with findings on coronary computed tomography angiography and fractional flow reserve. J Cardiovasc Comput Tomogr. 2020;14:483–9.PubMedCrossRef Hoshino M, Yang S, Sugiyama T, et al. Peri-coronary inflammation is associated with findings on coronary computed tomography angiography and fractional flow reserve. J Cardiovasc Comput Tomogr. 2020;14:483–9.PubMedCrossRef
37.
go back to reference Long Y, Guo R, Jin K, et al. Analysis of the perivascular fat attenuation index and quantitative plaque parameters in relation to haemodynamically impaired myocardial ischaemia. Int J Cardiovasc Imaging. 2024;40:1455–63.PubMedCrossRef Long Y, Guo R, Jin K, et al. Analysis of the perivascular fat attenuation index and quantitative plaque parameters in relation to haemodynamically impaired myocardial ischaemia. Int J Cardiovasc Imaging. 2024;40:1455–63.PubMedCrossRef
38.
go back to reference Ma S, Chen X, Ma Y et al. Lesion-specific peri-coronary fat attenuation index is associated with functional myocardial ischemia defined by abnormal fractional flow reserve. Front Cardiovasc Med. 2021;8. Ma S, Chen X, Ma Y et al. Lesion-specific peri-coronary fat attenuation index is associated with functional myocardial ischemia defined by abnormal fractional flow reserve. Front Cardiovasc Med. 2021;8.
39.
go back to reference Ishii Y, Abe I, Kira S, et al. Detection of fibrotic remodeling of epicardial adipose tissue in patients with atrial fibrillation: imaging approach based on histological observation. Heart Rhythm. 2021;O2(2):311–23.CrossRef Ishii Y, Abe I, Kira S, et al. Detection of fibrotic remodeling of epicardial adipose tissue in patients with atrial fibrillation: imaging approach based on histological observation. Heart Rhythm. 2021;O2(2):311–23.CrossRef
40.
go back to reference Chen M, Liu B, Li X, Li D, Fan L. Relationship between peri-coronary inflammation and coronary vascular function in patients with suspected coronary artery disease. Front Cardiovasc Med. 2024;11. Chen M, Liu B, Li X, Li D, Fan L. Relationship between peri-coronary inflammation and coronary vascular function in patients with suspected coronary artery disease. Front Cardiovasc Med. 2024;11.
41.
go back to reference Yamamoto T, Kawamori H, Toba T, et al. Impact of pericoronary adipose tissue attenuation on periprocedural myocardial injury in patients with chronic coronary syndrome. J Am Heart Assoc. 2024;13:e031209.PubMedPubMedCentralCrossRef Yamamoto T, Kawamori H, Toba T, et al. Impact of pericoronary adipose tissue attenuation on periprocedural myocardial injury in patients with chronic coronary syndrome. J Am Heart Assoc. 2024;13:e031209.PubMedPubMedCentralCrossRef
42.
go back to reference Gaibazzi N, Martini C, Botti A, Pinazzi A, Bottazzi B, Palumbo AA. Coronary inflammation by computed tomography pericoronary fat attenuation in MINOCA and Tako-Tsubo syndrome. J Am Heart Assoc. 2019;8: e013235.PubMedPubMedCentralCrossRef Gaibazzi N, Martini C, Botti A, Pinazzi A, Bottazzi B, Palumbo AA. Coronary inflammation by computed tomography pericoronary fat attenuation in MINOCA and Tako-Tsubo syndrome. J Am Heart Assoc. 2019;8: e013235.PubMedPubMedCentralCrossRef
43.
go back to reference Kitagawa T, Sentani K, Ikegami Y, Takasaki T, Takahashi S, Nakano Y. Relationship between clinical parameters and histological features of epicardial adipose tissue and aortic valve calcification assessed on computed tomography. Circ J. 2024;advpub. Kitagawa T, Sentani K, Ikegami Y, Takasaki T, Takahashi S, Nakano Y. Relationship between clinical parameters and histological features of epicardial adipose tissue and aortic valve calcification assessed on computed tomography. Circ J. 2024;advpub.
44.
go back to reference Chan K, Wahome E, Tsiachristas A, et al. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. Lancet (London, England). 2024;403:2606–18.PubMedCrossRef Chan K, Wahome E, Tsiachristas A, et al. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. Lancet (London, England). 2024;403:2606–18.PubMedCrossRef
45.
go back to reference Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest. 2017;127:74–82.PubMedPubMedCentralCrossRef Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest. 2017;127:74–82.PubMedPubMedCentralCrossRef
46.
go back to reference Chatterjee TK, Stoll LL, Denning GM, et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res. 2009;104:541–9.PubMedPubMedCentralCrossRef Chatterjee TK, Stoll LL, Denning GM, et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res. 2009;104:541–9.PubMedPubMedCentralCrossRef
47.
go back to reference Jiang J, Yin Y, Li Y et al. Impact of glycemic control on coronary inflammation evaluated by computed tomography pericoronary fat attenuation index in patients with acute coronary syndrome. RCM. 2023;24. Jiang J, Yin Y, Li Y et al. Impact of glycemic control on coronary inflammation evaluated by computed tomography pericoronary fat attenuation index in patients with acute coronary syndrome. RCM. 2023;24.
48.
go back to reference Liu Y, Dong Y, Wang X, Xu X. Association between metformin treatment and coronary artery inflammation based on pericoronary adipose tissue attenuation in type 2 diabetes mellitus patients. J Clin Hypertens (Greenwich). 2024;26:330–7.PubMedCrossRef Liu Y, Dong Y, Wang X, Xu X. Association between metformin treatment and coronary artery inflammation based on pericoronary adipose tissue attenuation in type 2 diabetes mellitus patients. J Clin Hypertens (Greenwich). 2024;26:330–7.PubMedCrossRef
49.
go back to reference Ichikawa K, Miyoshi T, Osawa K, et al. High pericoronary adipose tissue attenuation on computed tomography angiography predicts cardiovascular events in patients with type 2 diabetes mellitus: post-hoc analysis from a prospective cohort study. Cardiovasc Diabetol. 2022;21:44.PubMedPubMedCentralCrossRef Ichikawa K, Miyoshi T, Osawa K, et al. High pericoronary adipose tissue attenuation on computed tomography angiography predicts cardiovascular events in patients with type 2 diabetes mellitus: post-hoc analysis from a prospective cohort study. Cardiovasc Diabetol. 2022;21:44.PubMedPubMedCentralCrossRef
50.
go back to reference Gaborit B, Venteclef N, Ancel P, et al. Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovasc Res. 2015;108:62–73.PubMedCrossRef Gaborit B, Venteclef N, Ancel P, et al. Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovasc Res. 2015;108:62–73.PubMedCrossRef
51.
go back to reference Thanassoulis G, Massaro JM, O’Donnell CJ, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2010;3:345–50.PubMedPubMedCentralCrossRef Thanassoulis G, Massaro JM, O’Donnell CJ, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2010;3:345–50.PubMedPubMedCentralCrossRef
52.
go back to reference Masuda M, Mizuno H, Enchi Y, et al. Abundant epicardial adipose tissue surrounding the left atrium predicts early rather than late recurrence of atrial fibrillation after catheter ablation. J Interv Cardiac Electrophysiol Int J Arrhythm Pacing. 2015;44:31–7.CrossRef Masuda M, Mizuno H, Enchi Y, et al. Abundant epicardial adipose tissue surrounding the left atrium predicts early rather than late recurrence of atrial fibrillation after catheter ablation. J Interv Cardiac Electrophysiol Int J Arrhythm Pacing. 2015;44:31–7.CrossRef
53.
go back to reference Gaibazzi N, Martini C, Benatti G, Palumbo AA, Cacciola G, Tuttolomondo D. Atrial fibrillation and peri-atrial inflammation measured through adipose tissue attenuation on cardiac computed tomography. Diagnostics (Basel, Switzerland) 2021;11. Gaibazzi N, Martini C, Benatti G, Palumbo AA, Cacciola G, Tuttolomondo D. Atrial fibrillation and peri-atrial inflammation measured through adipose tissue attenuation on cardiac computed tomography. Diagnostics (Basel, Switzerland) 2021;11.
54.
go back to reference El Mahdiui M, Simon J, Smit JM, et al. Posterior left atrial adipose tissue attenuation assessed by computed tomography and recurrence of atrial fibrillation after catheter ablation. Circ Arrhythm Electrophysiol. 2021;14:e009135.PubMedCrossRef El Mahdiui M, Simon J, Smit JM, et al. Posterior left atrial adipose tissue attenuation assessed by computed tomography and recurrence of atrial fibrillation after catheter ablation. Circ Arrhythm Electrophysiol. 2021;14:e009135.PubMedCrossRef
55.
go back to reference Nodera M, Ishida T, Hasegawa K, et al. Epicardial adipose tissue density predicts the presence of atrial fibrillation and its recurrence after catheter ablation: three-dimensional reconstructed image analysis. Heart Vessels. 2024;39:696–705.PubMedCrossRef Nodera M, Ishida T, Hasegawa K, et al. Epicardial adipose tissue density predicts the presence of atrial fibrillation and its recurrence after catheter ablation: three-dimensional reconstructed image analysis. Heart Vessels. 2024;39:696–705.PubMedCrossRef
56.
go back to reference Hammache N, Pegorer-Sfes H, Benali K et al. Is there an association between epicardial adipose tissue and outcomes after paroxysmal atrial fibrillation catheter ablation? J Clin Med. 2021;10. Hammache N, Pegorer-Sfes H, Benali K et al. Is there an association between epicardial adipose tissue and outcomes after paroxysmal atrial fibrillation catheter ablation? J Clin Med. 2021;10.
57.
go back to reference Beyer C, Tokarska L, Stühlinger M, et al. Structural cardiac remodeling in atrial fibrillation. JACC Cardiovasc Imaging. 2021;14:2199–208.PubMedCrossRef Beyer C, Tokarska L, Stühlinger M, et al. Structural cardiac remodeling in atrial fibrillation. JACC Cardiovasc Imaging. 2021;14:2199–208.PubMedCrossRef
59.
go back to reference Huber AT, Fankhauser S, Wittmer S, et al. Epicardial adipose tissue dispersion at CT and recurrent atrial fibrillation after pulmonary vein isolation. Eur Radiol. 2024;34:4928–38.PubMedPubMedCentralCrossRef Huber AT, Fankhauser S, Wittmer S, et al. Epicardial adipose tissue dispersion at CT and recurrent atrial fibrillation after pulmonary vein isolation. Eur Radiol. 2024;34:4928–38.PubMedPubMedCentralCrossRef
60.
go back to reference Chen LQ, Scheiner J, Nashta NF, et al. Epicardial fat modifies the relationship between coronary calcium score and all-cause mortality: The St. Francis Heart Study. Am J Prev Cardiol. 2024;19:100689.PubMedPubMedCentralCrossRef Chen LQ, Scheiner J, Nashta NF, et al. Epicardial fat modifies the relationship between coronary calcium score and all-cause mortality: The St. Francis Heart Study. Am J Prev Cardiol. 2024;19:100689.PubMedPubMedCentralCrossRef
61.
go back to reference Commandeur F, Slomka PJ, Goeller M, et al. Machine learning to predict the long-term risk of myocardial infarction and cardiac death based on clinical risk, coronary calcium, and epicardial adipose tissue: a prospective study. Cardiovasc Res. 2019;116:2216–25.PubMedCentralCrossRef Commandeur F, Slomka PJ, Goeller M, et al. Machine learning to predict the long-term risk of myocardial infarction and cardiac death based on clinical risk, coronary calcium, and epicardial adipose tissue: a prospective study. Cardiovasc Res. 2019;116:2216–25.PubMedCentralCrossRef
62.
go back to reference Lu MT, Park J, Ghemigian K, et al. Epicardial and paracardial adipose tissue volume and attenuation - Association with high-risk coronary plaque on computed tomographic angiography in the ROMICAT II trial. Atherosclerosis. 2016;251:47–54.PubMedPubMedCentralCrossRef Lu MT, Park J, Ghemigian K, et al. Epicardial and paracardial adipose tissue volume and attenuation - Association with high-risk coronary plaque on computed tomographic angiography in the ROMICAT II trial. Atherosclerosis. 2016;251:47–54.PubMedPubMedCentralCrossRef
63.
go back to reference Goeller M, Achenbach S, Marwan M, et al. Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects. J Cardiovasc Comput Tomogr. 2018;12:67–73.PubMedCrossRef Goeller M, Achenbach S, Marwan M, et al. Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects. J Cardiovasc Comput Tomogr. 2018;12:67–73.PubMedCrossRef
64.
go back to reference Pandey NN, Sharma S, Jagia P, Kumar S. Epicardial fat attenuation, not volume, predicts obstructive coronary artery disease and high risk plaque features in patients with atypical chest pain. Br J Radiol. 2020;93. Pandey NN, Sharma S, Jagia P, Kumar S. Epicardial fat attenuation, not volume, predicts obstructive coronary artery disease and high risk plaque features in patients with atypical chest pain. Br J Radiol. 2020;93.
65.
go back to reference Zhu X, Chen X, Ma S, Zhou K, Hou Y. Dual-layer spectral detector CT to study the correlation between pericoronary adipose tissue and coronary artery stenosis. J Cardiothorac Surg. 2021;16:325.PubMedPubMedCentralCrossRef Zhu X, Chen X, Ma S, Zhou K, Hou Y. Dual-layer spectral detector CT to study the correlation between pericoronary adipose tissue and coronary artery stenosis. J Cardiothorac Surg. 2021;16:325.PubMedPubMedCentralCrossRef
66.
go back to reference Franssens BT, Nathoe HM, Leiner T, van der Graaf Y, Visseren FL, Group obotSs. Relation between cardiovascular disease risk factors and epicardial adipose tissue density on cardiac computed tomography in patients at high risk of cardiovascular events. Eur J Prev Cardiol. 2020;24:660–70.CrossRef Franssens BT, Nathoe HM, Leiner T, van der Graaf Y, Visseren FL, Group obotSs. Relation between cardiovascular disease risk factors and epicardial adipose tissue density on cardiac computed tomography in patients at high risk of cardiovascular events. Eur J Prev Cardiol. 2020;24:660–70.CrossRef
67.
go back to reference Molnar D, Björnson E, Larsson M, et al. Pre-diabetes is associated with attenuation rather than volume of epicardial adipose tissue on computed tomography. Sci Rep. 2023;13:1623.PubMedPubMedCentralCrossRef Molnar D, Björnson E, Larsson M, et al. Pre-diabetes is associated with attenuation rather than volume of epicardial adipose tissue on computed tomography. Sci Rep. 2023;13:1623.PubMedPubMedCentralCrossRef
68.
go back to reference Milanese G, Silva M, Bruno L, et al. Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: from the ALTER-BIO (Alternative Cardiovascular Bio-Imaging markers) registry. Diagn Interv Radiol (Ankara, Turkey). 2019;25:35–41.CrossRef Milanese G, Silva M, Bruno L, et al. Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: from the ALTER-BIO (Alternative Cardiovascular Bio-Imaging markers) registry. Diagn Interv Radiol (Ankara, Turkey). 2019;25:35–41.CrossRef
69.
go back to reference Liu J, Yu Q, Li Z, et al. Epicardial adipose tissue density is a better predictor of cardiometabolic risk in HFpEF patients: a prospective cohort study. Cardiovasc Diabetol. 2023;22:45.PubMedPubMedCentralCrossRef Liu J, Yu Q, Li Z, et al. Epicardial adipose tissue density is a better predictor of cardiometabolic risk in HFpEF patients: a prospective cohort study. Cardiovasc Diabetol. 2023;22:45.PubMedPubMedCentralCrossRef
70.
go back to reference Wang C-P, Hsu H-L, Hung W-C, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol. 2009;70:876–82.CrossRef Wang C-P, Hsu H-L, Hung W-C, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol. 2009;70:876–82.CrossRef
71.
go back to reference Nerlekar N, Thakur U, Lin A, et al. The natural history of epicardial adipose tissue volume and attenuation: a long-term prospective cohort follow-up study. Sci Rep. 2020;10:7109.PubMedPubMedCentralCrossRef Nerlekar N, Thakur U, Lin A, et al. The natural history of epicardial adipose tissue volume and attenuation: a long-term prospective cohort follow-up study. Sci Rep. 2020;10:7109.PubMedPubMedCentralCrossRef
72.
go back to reference Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2:536–43.PubMedCrossRef Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2:536–43.PubMedCrossRef
73.
go back to reference Corradi D, Maestri R, Callegari S, et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol. 2004;13:313–6.PubMedCrossRef Corradi D, Maestri R, Callegari S, et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol. 2004;13:313–6.PubMedCrossRef
74.
go back to reference Kocyigit D, Gurses KM, Yalcin MU, et al. Periatrial epicardial adipose tissue thickness is an independent predictor of atrial fibrillation recurrence after cryoballoon-based pulmonary vein isolation. J Cardiovasc Comput Tomogr. 2015;9:295–302.PubMedCrossRef Kocyigit D, Gurses KM, Yalcin MU, et al. Periatrial epicardial adipose tissue thickness is an independent predictor of atrial fibrillation recurrence after cryoballoon-based pulmonary vein isolation. J Cardiovasc Comput Tomogr. 2015;9:295–302.PubMedCrossRef
75.
go back to reference Tromp J, Bryant JA, Jin X, et al. Epicardial fat in heart failure with reduced versus preserved ejection fraction. Eur J Heart Fail. 2021;23:835–8.PubMedCrossRef Tromp J, Bryant JA, Jin X, et al. Epicardial fat in heart failure with reduced versus preserved ejection fraction. Eur J Heart Fail. 2021;23:835–8.PubMedCrossRef
76.
go back to reference Wu CK, Tsai HY, Su MM, et al. Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients. J Clin Lipidol. 2017;11:1421–31.PubMedCrossRef Wu CK, Tsai HY, Su MM, et al. Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients. J Clin Lipidol. 2017;11:1421–31.PubMedCrossRef
77.
go back to reference Demircelik MB, Yilmaz OC, Gurel OM, et al. Epicardial adipose tissue and pericoronary fat thickness measured with 64-multidetector computed tomography: potential predictors of the severity of coronary artery disease. Clinics (Sao Paulo, Brazil). 2014;69:388–92.PubMedCrossRef Demircelik MB, Yilmaz OC, Gurel OM, et al. Epicardial adipose tissue and pericoronary fat thickness measured with 64-multidetector computed tomography: potential predictors of the severity of coronary artery disease. Clinics (Sao Paulo, Brazil). 2014;69:388–92.PubMedCrossRef
78.
go back to reference Tuttolomondo D, Ticinesi A, Dey D, et al. Coronary inflammation on chest computed tomography and COVID-19 mortality. Eur Radiol. 2024;34:5153–63.PubMedCrossRef Tuttolomondo D, Ticinesi A, Dey D, et al. Coronary inflammation on chest computed tomography and COVID-19 mortality. Eur Radiol. 2024;34:5153–63.PubMedCrossRef
79.
go back to reference Dai X, Deng J, Yu M, Lu Z, Shen C, Zhang J. Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level. Int J Cardiovasc Imaging. 2020;36:723–30.PubMedCrossRef Dai X, Deng J, Yu M, Lu Z, Shen C, Zhang J. Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level. Int J Cardiovasc Imaging. 2020;36:723–30.PubMedCrossRef
80.
go back to reference Abazid RM, Smettei OA, Kattea MO, et al. Relation between epicardial fat and subclinical atherosclerosis in asymptomatic individuals. J Thorac Imaging. 2017;32:378–82.PubMedCrossRef Abazid RM, Smettei OA, Kattea MO, et al. Relation between epicardial fat and subclinical atherosclerosis in asymptomatic individuals. J Thorac Imaging. 2017;32:378–82.PubMedCrossRef
81.
go back to reference Lu Y, Wang T, Zhan R, et al. Effects of epicardial adipose tissue volume and density on cardiac structure and function in patients free of coronary artery disease. Jpn J Radiol. 2020;38:666–75.PubMedCrossRef Lu Y, Wang T, Zhan R, et al. Effects of epicardial adipose tissue volume and density on cardiac structure and function in patients free of coronary artery disease. Jpn J Radiol. 2020;38:666–75.PubMedCrossRef
Metadata
Title
Epicardial fat density obtained with computed tomography imaging - more important than volume?
Authors
Łukasz Nogajski
Maciej Mazuruk
Marta Kacperska
Mikołaj Kurpias
Maciej Mączewski
Maksymilian Nowakowski
Michał Mączewski
Ilona Michałowska
Przemysław Leszek
Aleksandra Paterek
Publication date
01-12-2024

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now